Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes Journal Article

Authors: Walsh, M. F.; Ritter, D. I.; Kesserwan, C.; Sonkin, D.; Chakravarty, D.; Chao, E.; Ghosh, R.; Kemel, Y.; Wu, G.; Lee, K.; Kulkarni, S.; Hedges, D.; Mandelker, D.; Ceyhan-Birsoy, O.; Luo, M.; Drazer, M.; Zhang, L.; Offit, K.; Plon, S. E.
Article Title: Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes
Abstract: In its landmark paper about Standards and Guidelines for the Interpretation of Sequence Variants, the American College of Medical Genetics and Genomics (ACMG), and Association for Molecular Pathology (AMP) did not address how to use tumor data when assessing the pathogenicity of germline variants. The Clinical Genome Resource (ClinGen) established a multidisciplinary working group, the Germline/Somatic Variant Subcommittee (GSVS) with this focus. The GSVS implemented a survey to determine current practices of integrating somatic data when classifying germline variants in cancer predisposition genes. The GSVS then reviewed and analyzed available resources of relevant somatic data, and performed integrative germline variant curation exercises. The committee determined that somatic hotspots could be systematically integrated into moderate evidence of pathogenicity (PM1). Tumor RNA sequencing data showing altered splicing may be considered as strong evidence in support of germline pathogenicity (PVS1) and tumor phenotypic features such as mutational signatures be considered supporting evidence of pathogenicity (PP4). However, at present, somatic data such as focal loss of heterozygosity and mutations occurring on the alternative allele are not recommended to be systematically integrated, instead, incorporation of this type of data should take place under the advisement of multidisciplinary cancer center tumor-normal sequencing boards. © 2018 Wiley Periodicals, Inc.
Keywords: germline; somatic; signature; hotspot; pm1; pp4; variant interpretation
Journal Title: Human Mutation
Volume: 39
Issue: 11
ISSN: 1059-7794
Publisher: Wiley Liss  
Date Published: 2018-11-01
Start Page: 1542
End Page: 1552
Language: English
DOI: 10.1002/humu.23640
PUBMED: 30311369
PROVIDER: scopus
PMCID: PMC6310222
Notes: Article -- Export Date: 1 November 2018 -- Source: Scopus
Citation Impact
MSK Authors
  1. Kenneth Offit
    616 Offit
  2. Liying Zhang
    109 Zhang
  3. Yelena Kemel
    30 Kemel
  4. Michael Francis Walsh
    77 Walsh
  5. Ozge Birsoy
    22 Birsoy